SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kailiang Zhang, Shanjun Zhu, Yanwei Liu, Xiaoqun Dong, Zhendong Shi, Anling Zhang, Chaoyong Liu, Luyue Chen, Jianwei Wei, Peiyu Pu, Jianning Zhang, Tao Jiang, Lei Han, Chunsheng Kang, ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity, Cancer Letters, 2015, 357, 1, 404

    CrossRef

  2. 2
    Emilia Svala, Anna I. Thorfve, Cecilia Ley, Helena K. Barreto Henriksson, Jane M. Synnergren, Anders H. Lindahl, Stina Ekman, Eva S. R. Skiöldebrand, Effects of interleukin-6 and interleukin-1β on expression of growth differentiation factor-5 and Wnt signaling pathway genes in equine chondrocytes, American Journal of Veterinary Research, 2014, 75, 2, 132

    CrossRef

  3. 3
    Shirine Mohamed, Lelia Pruna, Pierre Kaminsky, Augmentation du risque de tumeurs dans la dystrophie myotonique de type 1, La Presse Médicale, 2013, 42, 9, e281

    CrossRef

  4. 4
    Jose L. Orgaz, Victoria Sanz-Moreno, Emerging molecular targets in melanoma invasion and metastasis, Pigment Cell & Melanoma Research, 2013, 26, 1
  5. 5
    Corine Bertolotto, Melanoma: From Melanocyte to Genetic Alterations and Clinical Options, Scientifica, 2013, 2013, 1

    CrossRef

  6. 6
    Hans-Ingo Trompeter, Janine Dreesen, Eugenie Hermann, Katharina M Iwaniuk, Markus Hafner, Neil Renwick, Thomas Tuschl, Peter Wernet, MicroRNAs miR-26a, miR-26b, and miR-29b accelerate osteogenic differentiation of unrestricted somatic stem cells from human cord blood, BMC Genomics, 2013, 14, 1, 111

    CrossRef

  7. 7
    Chuan-Ming Xie, Wenyi Wei, Yi Sun, Role of SKP1-CUL1-F-Box-Protein (SCF) E3 Ubiquitin Ligases in Skin Cancer, Journal of Genetics and Genomics, 2013, 40, 3, 97

    CrossRef

  8. 8
    Pei-Tzu Yang, Jamie N. Anastas, Rachel A. Toroni, Michi M. Shinohara, Jamie M. Goodson, Anja K. Bosserhoff, Andy J. Chien, Randall T. Moon, WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis, EMBO Molecular Medicine, 2012, 4, 12
  9. 9
    Jamie N. Anastas, Randall T. Moon, WNT signalling pathways as therapeutic targets in cancer, Nature Reviews Cancer, 2012, 13, 1, 11

    CrossRef

  10. 10
    Ossia M. Eichhoff, Ashani Weeraratna, Marie C. Zipser, Laurence Denat, Daniel S. Widmer, Mai Xu, Lydia Kriegl, Thomas Kirchner, Lionel Larue, Reinhard Dummer, Keith S. Hoek, Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching, Pigment Cell & Melanoma Research, 2011, 24, 4
  11. You have free access to this content11
    Laura Held, Thomas K. Eigentler, Friedegund Meier, Marko Held, Martin Röcken, Claus Garbe, Jürgen Bauer, Oncogenetics of melanoma: basis for molecular diagnostics and therapy, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2011, 9, 7
  12. 12
    Daniela Göppner, Martin Leverkus, Prognostic Parameters for the Primary Care of Melanoma Patients: What Is Really Risky in Melanoma?, Journal of Skin Cancer, 2011, 2011, 1

    CrossRef

  13. 13
    William E. Damsky, David P. Curley, Manjula Santhanakrishnan, Lara E. Rosenbaum, James T. Platt, Bonnie E. Gould Rothberg, Makoto M. Taketo, David Dankort, David L. Rimm, Martin McMahon, Marcus Bosenberg, β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas, Cancer Cell, 2011, 20, 6, 741

    CrossRef

  14. 14
    Therese M. Becker, Suzanah Philipsz, Lyndee L. Scurr, Carina Fung, Sebastian Haferkamp, Richard F. Kefford, Helen Rizos, Oncogenic B-RAFV600E Promotes Anchorage-Independent Survival of Human Melanocytes, Journal of Investigative Dermatology, 2010, 130, 8, 2144

    CrossRef

  15. 15
    A. J. Chien, E. C. Moore, A. S. Lonsdorf, R. M. Kulikauskas, B. G. Rothberg, A. J. Berger, M. B. Major, S. T. Hwang, D. L. Rimm, R. T. Moon, Activated Wnt/ss-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model, Proceedings of the National Academy of Sciences, 2009, 106, 4, 1193

    CrossRef

  16. 16
    G. De Panfilis, D. Ferrari, S. Santoro, R. Ricci, M. Lombardi, G. Pedrazzi, C. Pepe, C. Cortelazzi, M. Santini, Cytoplasmic β-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?, British Journal of Dermatology, 2009, 160, 3
  17. 17
    Christine M. Mueller, James E. Hilbert, William Martens, Charles A. Thornton, Richard T. Moxley, Mark H. Greene, Hypothesis: neoplasms in myotonic dystrophy, Cancer Causes & Control, 2009, 20, 10, 2009

    CrossRef

  18. You have free access to this content18
    Silke Kuphal, Anja Bosserhoff, Recent progress in understanding the pathology of malignant melanoma, The Journal of Pathology, 2009, 219, 4
  19. 19
    Daniele Castiglia, Silvia Bernardini, Ester Alvino, Elena Pagani, Naomi De Luca, Sabrina Falcinelli, Alberto Pacchiarotti, Enzo Bonmassar, Giovanna Zambruno, Stefania D'Atri, Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma, Genes, Chromosomes and Cancer, 2008, 47, 7
  20. 20
    Kavita V. Shah, Andy J. Chien, Cassian Yee, Randall T. Moon, CTLA-4 Is a Direct Target of Wnt/β-Catenin Signaling and Is Expressed in Human Melanoma Tumors, Journal of Investigative Dermatology, 2008, 128, 12, 2870

    CrossRef

  21. 21
    H.-C. S. Yen, S. J. Elledge, Identification of SCF Ubiquitin Ligase Substrates by Global Protein Stability Profiling, Science, 2008, 322, 5903, 923

    CrossRef

  22. 22
    Pablo Lopez-Bergami, Boris Fitchman, Ze’ev Ronai, Understanding Signaling Cascades in Melanoma, Photochemistry and Photobiology, 2008, 84, 2
  23. 23
    Wieke Zuidervaart, Sandra Pavey, Frans A. van Nieuwpoort, Leisl Packer, Coby Out, Willem Maat, Martine J. Jager, Nelleke A. Gruis, Nicholas K. Hayward, Expression of Wnt5a and its downstream effector β-catenin in uveal melanoma, Melanoma Research, 2007, 17, 6, 380

    CrossRef

  24. 24
    A. Torres, L. Storey, M. Anders, R.L. Miller, B.J. Bulbulian, J. Jin, S. Raghavan, J. Lee, H.B. Slade, W. Birmachu, Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod, British Journal of Dermatology, 2007, 157, 6
  25. 25
    CHANG JAE KIM, JAE HWI SONG, YONG GU CHO, YOUNG SILL KIM, SU YOUNG KIM, SUK WOO NAM, NAM JIN YOO, JUNG YOUNG LEE, WON SANG PARK, Somatic mutations of the β-TrCP gene in gastric cancer, APMIS, 2007, 115, 2
  26. 26
    CHRISTINA DAHL, PER GULDBERG, The genome and epigenome of malignant melanoma, APMIS, 2007, 115, 10
  27. 27
    Paul Polakis, The many ways of Wnt in cancer, Current Opinion in Genetics & Development, 2007, 17, 1, 45

    CrossRef

  28. 28
    Wilson K. Clements, David Kimelman, LZIC regulates neuronal survival during zebrafish development, Developmental Biology, 2005, 283, 2, 322

    CrossRef

  29. 29
    Ichiro Okamoto, Christine Pirker, Martin Bilban, Walter Berger, Doris Losert, Christine Marosi, Oskar A. Haas, Klaus Wolff, Hubert Pehamberger, Seven Novel and Stable Translocations Associated with Oncogenic Gene Expression in Malignant Melanoma, Neoplasia, 2005, 7, 4, 303

    CrossRef

  30. 30
    J. Reifenberger, M. Wolter, C. B. Knobbe, B. Köhler, A. Schönicke, C. Scharwächter, K. Kumar, B. Blaschke, T. Ruzicka, G. Reifenberger, Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas, British Journal of Dermatology, 2005, 152, 1
  31. You have free access to this content31
    Mohammad Ilyas, Wnt signalling and the mechanistic basis of tumour development, The Journal of Pathology, 2005, 205, 2
  32. 32
    Tomonari Takahira, Yoshinao Oda, Sadafumi Tamiya, Hidetaka Yamamoto, Kenichi Kawaguchi, Chikashi Kobayashi, Yukihide Iwamoto, Masazumi Tsuneyoshi, Alterations of the p16INK4a/p14ARF pathway in clear cell sarcoma, Cancer Science, 2004, 95, 8
  33. 33
    A. Ougolkov, B. Zhang, K. Yamashita, V. Bilim, M. Mai, S. Y. Fuchs, T. Minamoto, Associations Among  -TrCP, an E3 Ubiquitin Ligase Receptor,  -Catenin, and NF- B in Colorectal Cancer, JNCI Journal of the National Cancer Institute, 2004, 96, 15, 1161

    CrossRef

  34. 34
    Yoshinori Sasaki, Chunbo Niu, Rui Makino, Chieko Kudo, Chunlan Sun, Hiroshi Watanabe, Jun Matsunaga, Kazuhiro Takahashi, Hachiro Tagami, Setsuya Aiba, Akira Horii, BRAF Point Mutations in Primary Melanoma Show Different Prevalences by Subtype, Journal of Investigative Dermatology, 2004, 123, 1, 177

    CrossRef

  35. 35
    Julia Reifenberger, Christiane B. Knobbe, Astrid A. Sterzinger, Britta Blaschke, Klaus W. Schulte, Thomas Ruzicka, Guido Reifenberger, Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas, International Journal of Cancer, 2004, 109, 3
  36. 36
    Monica Rodolfo, Maria Daniotti, Viviana Vallacchi, Genetic progression of metastatic melanoma, Cancer Letters, 2004, 214, 2, 133

    CrossRef

  37. 37
    Rooshdiya Z. Karim, Gary M.K. Tse, Thomas C. Putti, Richard A. Scolyer, C. Soon Lee, The significance of the Wnt pathway in the pathology of human cancers, Pathology, 2004, 36, 2, 120

    CrossRef

  38. 38
    Rachel H. Giles, Johan H. van Es, Hans Clevers, Caught up in a Wnt storm: Wnt signaling in cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2003, 1653, 1, 1

    CrossRef

  39. 39
    Lalita A. Shevde, Danny R. Welch, Metastasis suppressor pathways—an evolving paradigm, Cancer Letters, 2003, 198, 1, 1

    CrossRef

  40. 40
    Christopher Hull, April Larson, Sancy Leachman, Pharmacogenetic candidate genes for melanoma, Pharmacogenomics, 2003, 4, 6, 753

    CrossRef

  41. 41
    Thomas A Graham, Wilson K Clements, David Kimelman, Wenqing Xu, The Crystal Structure of the β-Catenin/ICAT Complex Reveals the Inhibitory Mechanism of ICAT, Molecular Cell, 2002, 10, 3, 563

    CrossRef

  42. 42
    Mohammad Ilyas, Wnt Signal Transduction, The Cancer Handbook,